HHM Wealth Advisors’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$672 Hold
7
﹤0.01% 847
2026
Q1
$765 Sell
7
-4
-36% -$381 ﹤0.01% 837
2025
Q4
$893 Hold
11
﹤0.01% 801
2025
Q3
$963 Hold
11
﹤0.01% 807
2025
Q2
$914 Hold
11
﹤0.01% 815
2025
Q1
$923 Sell
11
-1
-8% -$93 ﹤0.01% 842
2024
Q4
$1.11K Sell
12
-1
-8% -$96 ﹤0.01% 841
2024
Q3
$1.21K Buy
+13
New +$1.13K ﹤0.01% 723

Other funds holding LMAT

HHM Wealth Advisors's LMAT Position: Q2 2026 in Review

HHM Wealth Advisors held its LeMaitre Vascular (LMAT) position steady in Q2 2026 at 7 shares worth $672. The position accounts for ﹤0.01% of the portfolio, ranked #847.

HHM Wealth Advisors first reported a position in LMAT in Q3 2024 and has held it in 8 quarters since. The position peaked at $1.21K in Q3 2024. 65 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

  • HHM Wealth Advisors held 7 shares of LeMaitre Vascular worth $672 as of Q2 2026.
  • HHM Wealth Advisors left its LeMaitre Vascular share count unchanged in Q2 2026.
  • LeMaitre Vascular made up ﹤0.01% of HHM Wealth Advisors's portfolio in Q2 2026, its #847 holding.
  • HHM Wealth Advisors first reported a position in LeMaitre Vascular in Q3 2024 and has held it in 8 quarters since.
  • HHM Wealth Advisors's LeMaitre Vascular position peaked at $1.21K in Q3 2024.
  • 65 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on HHM Wealth Advisors's 13F filing for Q2 2026, filed 13 Jul 2026.